Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures

References

• Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers 2018;4:18001.
   PubMed Web of Science ®Google Scholar
• Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford) 2014;53:2143–54.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–7.
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A, Liu PP, Lanfear DE, de Boer RA, González A, Thum T, et al. Omics phenotyping in heart failure: the next frontier. Eur Heart J 2020;41:3477–84.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Huttin O, Magnusson M, Ferreira JP, Bozec E, Huby AC, et al. Machine learning-derived echocardiographic phenotypes predict heart failure incidence in asymptomatic individuals. JACC Cardiovasc Imaging 2021;15:193–208.
   PubMed Web of Science ®Google Scholar
• Woolley RJ, Ceelen D, Ouwerkerk W, Tromp J, Figarska SM, Anker SD, et al. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction. Eur J Heart Fail 2021;23:983–91.
   PubMed Web of Science ®Google Scholar
• Stienen S, Ferreira JP, Kobayashi M, Preud’homme G, Dobre D, Machu JL, et al. Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure). Biomarkers 2020;25:201–11.
   PubMed Web of Science ®Google Scholar
• Sabbah MS, Fayyaz AU, Denus S, Felker GM, Borlaug BA, Dasari S, et al. Obese-inflammatory phenotypes in heart failure with preserved ejection fraction. Circulation: Heart Failure 2020;13:e006414.
   PubMed Web of Science ®Google Scholar
• Ferreira MB, Fonseca T, Costa R, Marinhoc A, Carvalho HC, Oliveira JC, et al. Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: the RA-HF study. Eur J Intern Med 2021;85:41–9.
   PubMed Web of Science ®Google Scholar
• Villeneuve E, Nam J, Emery P. 2010 ACR-EULAR classification criteria for rheumatoid arthritis. Rev Bras Reumatol 2010;50:481–3.
   PubMedGoogle Scholar
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111–17.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233–70.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1–39 e14.
   PubMed Web of Science ®Google Scholar
• Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2015;74:480–9.
   PubMed Web of Science ®Google Scholar
• Blyszczuk P, Szekanecz Z. Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis. RMD Open 2020;6:e001032.
   PubMed Web of Science ®Google Scholar
• Rolski F, Blyszczuk P. Complexity of TNF-α signaling in heart disease. J Clin Med 2020;9:3267.
   PubMed Web of Science ®Google Scholar
• Roodenrijs NMT, van der Goes MC, Welsing PMJ, Tekstra J, Lafeber F, Jacobs JWG, et al. Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatology (Oxford) 2021;60:3778–88.
   PubMed Web of Science ®Google Scholar
• Jung SM, Park KS, Kim KJ. Clinical phenotype with high risk for initiation of biologic therapy in rheumatoid arthritis: a data-driven cluster analysis. Clin Exp Rheumatol 2021;39:1282–90.
   PubMed Web of Science ®Google Scholar
• Croft M, Siegel RM. Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases. Nat Rev Rheumatol 2017;13:217–33.
   PubMed Web of Science ®Google Scholar
• Wallentin L, Eriksson N, Olszowka M, Grammer TB, Hagstrom E, Held C, et al. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: a retrospective study. PLoS Med 2021;18:e1003513.
   PubMed Web of Science ®Google Scholar
• Eggers KM, Lindhagen L, Baron T, Erlinge D, Hjort M, Jernberg T, et al. Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers. Eur Heart J Acute Cardiovasc Care 2021;10:806–12.
   PubMed Web of Science ®Google Scholar
• Skau E, Henriksen E, Wagner P, Hedberg P, Siegbahn A, Leppert J. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction. Eur J Prev Cardiol 2017;24:1576–83.
   PubMed Web of Science ®Google Scholar
• Lind L, Arnlov J, Sundstrom J. Plasma protein profile of incident myocardial infarction, ischemic stroke, and heart failure in 2 cohorts. J Am Heart Assoc 2021;10:e017900.
   PubMed Web of Science ®Google Scholar
• Hong Y, Xie W, Chen CS. Effect of shengmai injection on TRAIL death receptor of patients with congestive heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005;25:1092–5.
   PubMedGoogle Scholar
• Kotake S, Nanke Y, Mogi M, Kawamoto M, Furuya T, Yago T, et al. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol 2005;35:3353–63.
   PubMed Web of Science ®Google Scholar
• Ferreira JP, Verdonschot J, Collier T, Wang P, Pizard A, Bar C, et al. Proteomic bioprofiles and mechanistic pathways of progression to heart failure. Circ Heart Fail 2019;12:e005897.
   PubMed Web of Science ®Google Scholar